2-acetamido-8-hydroxyquinoline | 312591-57-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2-acetamido-8-hydroxyquinoline
• 英文别名: N-(8-hydroxyquinolin-2-yl)acetamide
• CAS: 312591-57-4
• 化学式: C₁₁H₁₀N₂O₂
• mdl: MFCD00168946
• 分子量: 202.213
• InChiKey: LOLPGXCBKGETOO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  62.2
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  zinc diacetate 、 水 、 2-acetamido-8-hydroxyquinoline 以 甲醇 为溶剂， 以78%的产率得到
  参考文献：
  名称：

  Zinc(II) complexes of amide- and urea-substituted 8-hydroxyquinolines

  摘要：

  A series of amide- and urea-substituted 8-hydroxyquinoline ligands 1-6-H are used for the formation of zinc(II) complexes. Hereby in general 2:1 complexes are obtained and the X-ray structure of [(3)(2)Zn] reveals the presence of a coordination polymer in the solid state. Only the derivatives of 7-amino-8-hydroxyquinoline 4-H and 5-H form trinuclear hexa-helical 6:3 complexes which exhibit interesting structural and NMR and fluorescence spectroscopic properties. (C) 2002 Elsevier Science B.V. All rights reserved.

  DOI：

  10.1016/s0020-1693(02)01201-x
• 作为产物：
  描述：

  1-乙酰基咪唑 、 2-氨基-8-羟基喹啉 以 四氢呋喃 为溶剂， 以89%的产率得到2-acetamido-8-hydroxyquinoline
  参考文献：
  名称：

  酰胺和脲取代的8-羟基喹啉衍生物中的分子间和分子内氢键

  摘要：

  酰胺和脲基取代的8-羟基喹啉衍生物3，5，和7是通过标准方法制备。在固态3a，5d和7中，形成具有分叉的分子间和分子内氢键的8-羟基喹啉二聚体。

  DOI：

  10.1016/s0040-4020(01)01168-1

文献信息

• [EN] 8-HYDROXY QUINOLINE DERIVATIVES<br/>[FR] DERIVES DE QUINOLINE 8-HYDROXY
  申请人：PRANA BIOTECHNOLOGY LTD

  公开号：WO2004007461A1

  公开（公告）日：2004-01-22

  The present invention relates to a method for the treatment, amelioration and/or prophylaxis of a neurological condition, in particular neurodegenerative disorders which comprises the administration of an effective amount of a compound of formula (I): to a subject in need thereof. The present invention also relates to a compound of formula (II) and processes for its preparation.

  本发明涉及一种用于治疗、改善和/或预防神经系统疾病，特别是神经退行性疾病的方法，包括向需要的受试者施用化合物(I)的有效量。本发明还涉及一种化合物(II)及其制备方法。
• 8-HYDROXY QUINOLINE DERIVATIVES
  申请人：PRANA BIOTECHNOLOGY LIMITED

  公开号：US20150094334A1

  公开（公告）日：2015-04-02

  The present invention describes a method for the treatment of a neurological condition in a subject which comprises administering to a subject in need thereof a therapeutically effect amount of a compound of the formula or pharmaceutically acceptable salts, hydrates, or solvates thereof.

  本发明描述了一种治疗受试者神经疾病的方法，包括向需要治疗的受试者施用公式中的化合物或其药学上可接受的盐、水合物或溶剂化物的治疗有效量。
• 8-Hydroxy quinoline derivatives
  申请人：Barnham Kevin Jeffrey

  公开号：US20080161353A1

  公开（公告）日：2008-07-03

  The present invention describes a method for the treatment of a neurological condition in a subject which comprises administering to a subject in need thereof a therapeutically effect amount of a compound of the formula or pharmaceutically acceptable salts, hydrates, or solvates thereof.

  本发明描述了一种治疗主体神经系统疾病的方法，该方法包括向需要治疗的主体中给予一定治疗效果的化合物，该化合物的化学式如下，或其药学上可接受的盐、水合物或溶剂化物。
• METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME
  申请人：Bush Ashley

  公开号：US20100069393A1

  公开（公告）日：2010-03-18

  The present invention relates generally to therapeutic agents, formulations comprising them and their use in the treatment, amelioration and/or prophylaxis of glioma brain tumours and related conditions. The therapeutic agent comprises two fused 6-membered rings with at least a nitrogen at position 1 and a hydroxyl at position 8.
• US7619091B2
  申请人：——

  公开号：US7619091B2

  公开（公告）日：2009-11-17